Published in J Clin Invest on December 01, 1976
A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J (1985) 2.77
Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A (1977) 2.01
Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes. Biochem J (1978) 1.51
Effect of fasting and streptozotocin diabetes on insulin binding and action in the isolated mouse soleus muscle. J Clin Invest (1979) 1.50
Divergent mechanisms for the insulin resistant and hyperresponsive glucose transport in adipose cells from fasted and refed rats. Alterations in both glucose transporter number and intrinsic activity. J Clin Invest (1988) 1.32
Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism. Proc Natl Acad Sci U S A (1978) 1.18
Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin. J Clin Invest (1982) 1.17
Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Proc Natl Acad Sci U S A (1980) 1.16
Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochem J (1992) 1.06
Insulin action and binding in isolated hepatocytes from fasted, streptozotocin-diabetic, and older, spontaneously obese rats. Biochem J (1980) 1.05
Effect of nutritional status on insulin sensitivity in vivo and tissue enzyme activities in the rat. Biochem J (1989) 1.05
Regulation of glucose transporter-specific mRNA levels in rat adipose cells with fasting and refeeding. Implications for in vivo control of glucose transporter number. J Clin Invest (1989) 0.99
Glucagon inhibition of insulin-stimulated 2-deoxyglucose uptake by rat adipocytes in the presence of adenosine deaminase. Biochem J (1983) 0.91
Insulin action on adipocytes. Evidence that the anti-lipolytic and lipogenic effects of insulin are mediated by the same receptor. Biochem J (1979) 0.90
Retracted Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model. J Clin Invest (1977) 0.89
In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies. J Clin Invest (1991) 0.87
Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells. J Clin Invest (1995) 0.86
The role for adipose tissue in weight regain after weight loss. Obes Rev (2015) 0.86
Insulin resistance in uremia. Characterization of insulin action, binding, and processing in isolated hepatocytes from chronic uremic rats. J Clin Invest (1983) 0.83
Morphological change in pancreatic islets, insulin binding and intracellular glucose metabolism in adipocytes of streptozotocin-induced diabetic rats. Korean J Intern Med (1987) 0.80
Effect of insulin on glucose transport and metabolism in isolated fat-cells of gonadal adipose tissue from mature age-matched male and female rats. Biochem J (1985) 0.79
Effects of fasting on hepatic and peripheral glucose metabolism in conscious rats with near-total fat depletion. Biochem J (1995) 0.79
Effects of streptozotocin diabetes and fasting on intracellular sodium and adenosine triphosphate in rat soleus muscle. J Physiol (1983) 0.79
Mechanisms of fasting-induced increase in insulin binding to rat adipocytes. J Clin Invest (1978) 0.78
The effect of fasting on the activation in vivo of the insulin receptor kinase. Biochem J (1990) 0.75
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem (1964) 21.04
Hormone-fuel interrelationships during fasting. J Clin Invest (1966) 6.44
Methods for the determination of adipose cell size in man and animals. J Lipid Res (1968) 5.47
Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab (1971) 5.20
Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem (1957) 4.79
Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun (1971) 3.74
Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun (1973) 3.41
The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. Studies with intact and trypsin-treated fat cells. J Biol Chem (1971) 3.32
Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. J Biol Chem (1974) 3.04
Transport of sugars in tumor cell membranes. Biochim Biophys Acta (1974) 2.72
Characteristics of the human lymphocyte insulin receptor. J Biol Chem (1973) 2.61
Hexose transport in normal and in Rous sarcoma virus-transformed cells. J Biol Chem (1973) 2.50
A procedure for measurement of distribution spaces in isolated fat cells. Biochim Biophys Acta (1972) 2.22
A simple method to determine fat cell size and number in four mammalian species. Am J Physiol (1971) 2.22
Binding and degradation of 125I-labelled insulin by isolated rat fat cells. Biochim Biophys Acta (1973) 2.14
Cooperativity in ligand binding: a new graphic analysis. Biochem Biophys Res Commun (1975) 1.87
The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1976) 1.75
Permeation of glucose by simple and facilitated diffusion by Novikoff rat hepatoma cells in suspension culture and its relationship to glucose metabolism. J Biol Chem (1972) 1.68
Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1975) 1.59
Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat. J Biol Chem (1974) 1.55
Insulin binding to isolated human adipocytes. Diabetes (1974) 1.53
Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology (1975) 1.50
Hexose transport in isolated brown fat cells. A model system for investigating insulin action on membrane transport. J Biol Chem (1974) 1.39
Sugar transport in chick embryo fibroblasts. I. A functional change in the plasma membrane associated with the rate of cell growth. J Biol Chem (1974) 1.35
The human lymphocyte: a model for the study of insulin-receptor interaction. J Clin Endocrinol Metab (1974) 1.25
Variations in glucose metabolism and sensitivity to insulin of the rat's adipose tissue, in relation to age and body weight. Endocrinology (1968) 1.24
The effects of acute and chronic dexamethasone administration on insulin binding to isolated rat hepatocytes and adipocytes. Metabolism (1975) 1.12
Interactions polypeptide hormones with cell membrane specific receptors: studies with insulin and glucagon. Diabetologia (1976) 1.01
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol (2000) 4.25
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest (1981) 3.34
Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes (1996) 3.21
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest (1980) 3.10
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest (1987) 2.81
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest (2000) 2.67
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem (1987) 2.48
The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes (1985) 2.46
LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes (1981) 2.40
The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes (1976) 2.15
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Mechanisms of insulin resistance in aging. J Clin Invest (1983) 2.00
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care (1992) 1.92
In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest (1986) 1.87
Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med (1974) 1.84
Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem (1994) 1.79
Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest (1987) 1.76
The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1976) 1.75
Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem (1996) 1.74
Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem (1996) 1.71
Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care (1983) 1.71
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest (1975) 1.69
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. J Clin Invest (1976) 1.66
Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes. Bioinformatics (2004) 1.65
Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation. J Biol Chem (1995) 1.65
Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes (1996) 1.60
Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1975) 1.59
G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol (1999) 1.58
Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes (1990) 1.54
Insulin binding to isolated human adipocytes. Diabetes (1974) 1.53
Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1985) 1.51
Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes. Biochem J (1978) 1.51
Effects of streptozotocin-induced diabetes on insulin binding, glucose transport, and intracellular glucose metabolism in isolated rat adipocytes. Diabetes (1979) 1.50
Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology (1975) 1.50
Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes (1977) 1.49
Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest (1988) 1.49
Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes (1994) 1.46
Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Investig Med (1996) 1.45
Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling. J Biol Chem (1996) 1.45
Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem (1994) 1.43
Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med (1981) 1.43
Effects of lysosomotropic agents on insulin interactions with adipocytes. Evidence for a lysosomal pathway for insulin processing and degradation. J Biol Chem (1979) 1.42
Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes (1986) 1.41
Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem (1987) 1.41
Evidence for recycling of insulin receptors in isolated rat adipocytes. J Biol Chem (1981) 1.38
Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol (1982) 1.38
Decreased insulin binding to lymphocytes from diabetic subjects. J Clin Invest (1974) 1.37
The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem (2000) 1.35
beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem (2001) 1.35
Relationship between in vivo insulin resistance and decreased insulin receptors in obese man. J Clin Endocrinol Metab (1979) 1.34
Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc Natl Acad Sci U S A (1994) 1.33
Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest (1985) 1.32
Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol Cell Biol (1994) 1.31
Insulin can regulate GLUT4 internalization by signaling to Rab5 and the motor protein dynein. Proc Natl Acad Sci U S A (2001) 1.31
Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity. J Clin Invest (1981) 1.30
Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway. J Biol Chem (1995) 1.30
Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes. J Clin Invest (1985) 1.29
Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes. Endocrinology (2000) 1.29
Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport. J Biol Chem (1998) 1.28
Evidence for insulin-induced internalization and degradation of insulin receptors in rat adipocytes. Proc Natl Acad Sci U S A (1982) 1.27
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes (2001) 1.27
Effects of insulin incubation on insulin binding, glucose transport, and insulin degradation by isolated rat adipocytes. Evidence for hormone-induced desensitization at the receptor and postreceptor level. J Clin Invest (1980) 1.26
Role of glucose transport in the postreceptor defect of non-insulin-dependent diabetes mellitus. Diabetes (1982) 1.26
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab (1992) 1.26
In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism (1990) 1.26
Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J Biol Chem (2001) 1.24
Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J Biol Chem (1994) 1.23
Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J Biol Chem (1998) 1.22
The small guanosine triphosphate-binding protein Rab4 is involved in insulin-induced GLUT4 translocation and actin filament rearrangement in 3T3-L1 cells. Endocrinology (1997) 1.21
Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes (1986) 1.20
Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J Biol Chem (1999) 1.20
Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism. Proc Natl Acad Sci U S A (1978) 1.18
Interactions between insulin and its receptors after the initial binding event. Functional heterogeneity and relationships to insulin degradation. Diabetes (1979) 1.18
Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest (1988) 1.18
Structural differences between insulin receptors in the brain and peripheral target tissues. J Biol Chem (1983) 1.17
Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes. An in vitro system to measure histone kinase activity of insulin receptors activated in vivo. J Biol Chem (1986) 1.16
Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Diabetologia (1977) 1.16
Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. Diabetes (1998) 1.15
Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes (2000) 1.14
Insulin-stimulated glucose transport in human adipocytes. Am J Physiol (1979) 1.14
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. J Clin Invest (1984) 1.13
The effects of acute and chronic dexamethasone administration on insulin binding to isolated rat hepatocytes and adipocytes. Metabolism (1975) 1.12
Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects. J Biol Chem (1987) 1.11
Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes (1986) 1.10
Regulation of insulin receptors: evidence for involvement of an endocytotic internalization pathway. Proc Natl Acad Sci U S A (1980) 1.10
Surface binding and rates of internalization of 125I-insulin in adipocytes and IM-9 lymphocytes. J Biol Chem (1982) 1.10
Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am J Med (1976) 1.09
Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med (1985) 1.08
Biochemical and functional heterogeneity of rat adipocyte glucose transporters. J Biol Chem (1986) 1.08
Insulin receptor kinase activity in rat liver. Regulation by fasting and high carbohydrate feeding. J Biol Chem (1985) 1.08
Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes (1995) 1.08
Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol (1990) 1.08
Effects of insulin and insulin-like agents on the glucose transport system of cultured human fibroblasts. Diabetes (1981) 1.07
Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients. J Clin Endocrinol Metab (1984) 1.07
Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes (1974) 1.07
TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes (1997) 1.06
The functional role of CrkII in actin cytoskeleton organization and mitogenesis. J Biol Chem (1999) 1.06
Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. J Clin Endocrinol Metab (1983) 1.05